Table 3 Characterization of BMD and BMC parameters in breast cancer patients (n = 40)
From: Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients
Parameter | Basala (No treatment) | 6 monthsa (After treatment) | Δb | p c | Confidence Interval 95 % |
|---|---|---|---|---|---|
BMD femoral neck (g/cm2) | 1.02 ± 0.1 | 1.001 ± 0.1 | −0.018 | <0.001 | (−0.026, −0.011) |
BMD L2-L4 (g/cm2) | 1.19 ± 0.2 | 1.15 ± 0.1 | −0.048 | <0.001 | (−0.063, −0.033) |
BMC (kg) | 2.46 ± 0.34 | 2.43 ± 0.34 | −0.032 | 0.066 | (−0.065, 0.002) |